e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
To treat or not to treat, and how? Sleep-disordered breathing I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reductions in body weight and sleep apnea severity in morbidly obese subjects – Which factors contribute to improvements in lung function and blood gases?
Anne Marie Gabrielsen (Skien, Norway), Anne Marie Gabrielsen, Jøran Hjelmesæth, May Brit Lund, Jan Magnus Fredheim, Sverre Lehmann, Dag Hofsø
Source:
International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Session:
To treat or not to treat, and how? Sleep-disordered breathing I
Session type:
Thematic Poster Session
Number:
2408
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anne Marie Gabrielsen (Skien, Norway), Anne Marie Gabrielsen, Jøran Hjelmesæth, May Brit Lund, Jan Magnus Fredheim, Sverre Lehmann, Dag Hofsø. Reductions in body weight and sleep apnea severity in morbidly obese subjects – Which factors contribute to improvements in lung function and blood gases?. Eur Respir J 2015; 46: Suppl. 59, 2408
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor?
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Impaired control of gait in patients with severe obstructive sleep apnea is reversed by continuous positive airway pressure treatment
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
Can we use the oxygen desaturation index alone to reliably diagnose obstructive sleep apnoea in obese patients?
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016
Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016
Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014
Comparison of peri-pharyngeal muscle recruitment during upper airway obstruction in patients with OSA and healthy subjects during wakefulness and sleep
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Pulmonary function tests (PFT) and sleep disordered breathing (SDB) in morbidly obese children and adults
Source: International Congress 2016 – Latest advances in paediatric sleep medicine
Year: 2016
Management of eucapnic obese patients with sleep disordered breathing (SDB)
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Severity of sleep apnea and daytime hypoxemia do not significantly contribute to endothelial dysfunction in morbidly obese subjects
Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research
Year: 2010
Anthropometric markers of adiposity and visceral adiposity index (VAI) in patients with OSA
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Source: Eur Respir J 2009; 34: 694
Year: 2009
The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Effects of alveolar hypoventilation on nighttime plasma glucose in obese patients
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014
Upper airway stimulation in OSA patients increases airway size in a dose-response manner
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013
Continuous positive airway pressure therapy for obstructive sleep apnoea: Do patients who request to have a copy of their letters have better compliance?
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
Obstructive sleep apnea contribution to blood antioxidant status of excess body mass index persons
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept